XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.1
Revenue Recognition (Details) - USD ($)
$ in Thousands
3 Months Ended
Jul. 13, 2022
Mar. 31, 2023
Mar. 31, 2022
Disaggregation of Revenue [Line Items]      
Net revenue   $ 76,372 $ 90,059
UNITED STATES | Net Product Sales | Geographic Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration Risk, Percentage   99.00%  
GIAPREZA      
Disaggregation of Revenue [Line Items]      
Net revenue   $ 9,000  
XERAVA      
Disaggregation of Revenue [Line Items]      
Net revenue   2,500  
GSK      
Disaggregation of Revenue [Line Items]      
Percentage of royalty payments not entitled to receive 15.00%    
Net revenue   56,858 $ 90,059
La Jolla      
Disaggregation of Revenue [Line Items]      
Net revenue   $ 11,500